PE20001026A1 - Procedimiento para preparar sales de trovafloxacina de adicion de acidos - Google Patents

Procedimiento para preparar sales de trovafloxacina de adicion de acidos

Info

Publication number
PE20001026A1
PE20001026A1 PE1999000878A PE00087899A PE20001026A1 PE 20001026 A1 PE20001026 A1 PE 20001026A1 PE 1999000878 A PE1999000878 A PE 1999000878A PE 00087899 A PE00087899 A PE 00087899A PE 20001026 A1 PE20001026 A1 PE 20001026A1
Authority
PE
Peru
Prior art keywords
acid
procedure
water
compound
trovafloxacin
Prior art date
Application number
PE1999000878A
Other languages
English (en)
Spanish (es)
Inventor
Keith Michael Devries
Peter Robert Rose
Timothy Norris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20001026A1 publication Critical patent/PE20001026A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
PE1999000878A 1998-09-03 1999-09-01 Procedimiento para preparar sales de trovafloxacina de adicion de acidos PE20001026A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
PE20001026A1 true PE20001026A1 (es) 2000-10-11

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000878A PE20001026A1 (es) 1998-09-03 1999-09-01 Procedimiento para preparar sales de trovafloxacina de adicion de acidos

Country Status (40)

Country Link
US (1) US6359137B1 (enExample)
EP (1) EP0989119A1 (enExample)
JP (1) JP3354526B2 (enExample)
KR (1) KR20000022858A (enExample)
CN (1) CN1248580A (enExample)
AP (1) AP1118A (enExample)
AR (1) AR021475A1 (enExample)
AU (1) AU761035B2 (enExample)
BG (1) BG103703A (enExample)
BR (1) BR9904082A (enExample)
CA (1) CA2281244C (enExample)
CO (1) CO5251466A1 (enExample)
EA (1) EA002340B1 (enExample)
EE (1) EE04118B1 (enExample)
GE (1) GEP20022785B (enExample)
GT (1) GT199900142A (enExample)
HN (1) HN1999000141A (enExample)
HR (1) HRP990274A2 (enExample)
HU (1) HUP9902967A3 (enExample)
ID (1) ID23718A (enExample)
IL (1) IL131614A0 (enExample)
IN (1) IN191583B (enExample)
IS (1) IS5168A (enExample)
MA (1) MA24966A1 (enExample)
MY (1) MY130800A (enExample)
NO (1) NO994261L (enExample)
NZ (1) NZ337605A (enExample)
OA (1) OA11152A (enExample)
PA (1) PA8481001A1 (enExample)
PE (1) PE20001026A1 (enExample)
PL (1) PL335246A1 (enExample)
SG (1) SG74748A1 (enExample)
SK (1) SK116599A3 (enExample)
SV (1) SV1999000144A (enExample)
TN (1) TNSN99164A1 (enExample)
TR (1) TR199902138A2 (enExample)
TW (1) TW520369B (enExample)
UY (1) UY25686A1 (enExample)
YU (1) YU43199A (enExample)
ZA (1) ZA995630B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
PL179996B1 (en) * 1994-01-18 2000-11-30 Pfizer Method of and intermediate products for obtaining salts of naphtyridinocarboxylic acids
WO1996039406A1 (en) * 1995-06-06 1996-12-12 Pfizer Inc. NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
HUP9900170A3 (en) * 1995-08-29 1999-11-29 Pfizer Zwitterionic forms of trovafloxacin, process for producing them and medicaments containing the same
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates

Also Published As

Publication number Publication date
HRP990274A2 (en) 2000-10-31
PL335246A1 (en) 2000-03-13
YU43199A (sh) 2002-11-15
HUP9902967A3 (en) 2000-11-28
SG74748A1 (en) 2000-08-22
HUP9902967A2 (hu) 2000-05-28
US6359137B1 (en) 2002-03-19
CA2281244C (en) 2003-05-20
AR021475A1 (es) 2002-07-24
BG103703A (bg) 2001-08-31
NO994261L (no) 2000-03-06
PA8481001A1 (es) 2000-09-29
CO5251466A1 (es) 2003-02-28
AU761035B2 (en) 2003-05-29
HN1999000141A (es) 2000-06-19
GT199900142A (es) 2001-02-15
NO994261D0 (no) 1999-09-02
ID23718A (id) 2000-05-11
BR9904082A (pt) 2000-09-12
EA199900708A3 (ru) 2000-08-28
MA24966A1 (fr) 2000-04-01
IS5168A (is) 2000-03-04
HU9902967D0 (en) 1999-10-28
JP2000086658A (ja) 2000-03-28
AU4482699A (en) 2000-03-16
TW520369B (en) 2003-02-11
SV1999000144A (es) 2000-09-05
AP1118A (en) 2002-11-21
SK116599A3 (en) 2000-05-16
IL131614A0 (en) 2001-01-28
CN1248580A (zh) 2000-03-29
EA002340B1 (ru) 2002-04-25
GEP20022785B (en) 2002-09-25
TR199902138A2 (xx) 2000-04-21
EE04118B1 (et) 2003-08-15
CA2281244A1 (en) 2000-03-03
NZ337605A (en) 2001-03-30
ZA995630B (en) 2001-03-01
IN191583B (enExample) 2003-12-06
EA199900708A2 (ru) 2000-04-24
MY130800A (en) 2007-07-31
AP9901667A0 (en) 1999-12-31
JP3354526B2 (ja) 2002-12-09
UY25686A1 (es) 2000-03-31
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
EE9900457A (et) 2000-04-17
TNSN99164A1 (fr) 2005-11-10
EP0989119A1 (en) 2000-03-29

Similar Documents

Publication Publication Date Title
ES2653421T3 (es) Compuestos de tetrahidropirrolotiazina
ES2698626T3 (es) Hidrólisis y alcohólisis selectivas de bencenos clorados
ES8207520A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
PA8645701A1 (es) Procedimiento para producir derivados de amina opticamente activos
PE20001086A1 (es) Procedimiento para la preparacion de pirazolo [4,3-d] pirimidin-7-onas y sus intermedios
PE20001026A1 (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos
PE20020590A1 (es) Procedimiento para la preparacion de imidazotriazinonas sustituidas con sulfonamida
ES2923623T3 (es) Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
Kirk et al. Photochemistry of diazonium salts. III. New and facile synthesis of 4-fluorimidazoles
NO842717L (no) Fremgangsmaate til fremstilling av karboksylsyrederivater og kjemisk forbindelse til utfoerelse av fremgangsmaaten
ES8306742A1 (es) "un procedimiento para la preparacion de 4-(4-imidazolil)-piridinas 2-sustituidas".
GEP19971008B (en) Mixture of quinolinecarboxylic acid and boric acid anhydride as intermediate derivatives of piperazinyl-3-quinolincarboxylic acid with antibacterial activity
KR840005430A (ko) 제초제용 n-페닐 피라졸유도체의 제조방법
ES8600730A1 (es) Procedimiento para la preparacion de agentes anti-psoriaticos del tipo naftalenico
MX9700938A (es) Preparacion de acidos sacarincarboxilicos y esteres de acido carboxilico.
CA2184051A1 (en) Process for preparing 4-bromophenyl alkyl ethers
PE20010682A1 (es) Procedimiento para la preparacion de compuestos de pirazolo [4,3-d] pirimidin-7-onas-3-piridilsulfonilo e intermedios de los mismos
ES8304975A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ES8404686A1 (es) Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico.
IT1201443B (it) Intermedi per la sintesi di acidi carbossilici
AR247553A1 (es) Procedimiento de preparacion de los acidos 4-oxo-3-quinolincarboxilicos utiles como agentes antibacterianos
ES8300681A1 (es) Procedimiento para preparar amidas.
IE64109B1 (en) A process for the preparation of 4-halo-3-oxo-2-alkoxy-iminobutyric esters
ES8301919A1 (es) Procedimiento para preparar derivados de indano
EP1179532B1 (en) Process for the production of indole derivatives and intermediates therefor

Legal Events

Date Code Title Description
FC Refusal